Home
About Us
Meet the Team
Product
Blog
Careers
Contact Us
Client Login
Home
About Us
Meet the Team
Product
Blog
Careers
Contact Us
Client Login
Nephron Blog
September 18, 2023
Trends in Profitability and Compensation of PBMs and PBM Contracting Entities
September 11, 2023
Protected: Nephron Call – CVS Launches Cordavis Biosimilar Subsidiary – Sept. 8th – REPLAY
September 11, 2023
Protected: KOL Call – Impact of Medicaid Redeterminations – Sept. 8th – REPLAY
September 8, 2023
Protected: China Tools & Dx Market Update KOL Call – Sept. 8th – REPLAY
August 18, 2023
Protected: Renal Denervation: What to Expect from FDA Advisory Panel & Reimbursement Outlook – Aug 18th – REPLAY
August 18, 2023
Protected: Market Access Strategies – IQVIA & UPMC Health Plan – Aug 17th – REPLAY
August 18, 2023
Protected: KOL Views on Clinical Trials for CROs & Tools – Aug 16th – REPLAY
August 15, 2023
Protected: Making Sense of Distributor & Pharmacy GLP-1 Trends – Aug. 10th – REPLAY
August 10, 2023
Protected: Nephron GLP-1 Impact Call – August 9th – REPLAY
July 31, 2023
Protected: KOL Call On Current State of Medicare Advantage – July 27 – REPLAY
July 17, 2023
Protected: PBMs in Peril? The 2023 Nephron Research PBM Innovation Symposium – July 11th – REPLAY
July 14, 2023
Protected: Orbitrap vs timsTOF – The Battle for MS Proteomics Supremacy? – July 13th – REPLAY
July 5, 2023
Protected: ADA Takeaways KOL Call – June 28th – REPLAY
July 5, 2023
Protected: KOL Call on Lab/Dx Industry Updates – June 27th – REPLAY
June 23, 2023
Diabetes Week at Nephron – Survey Work, Expert Events, GLP-1’s & More
Posts navigation
1
2
…
14
>>